Research Management Committee
Kids Brain Health Network’s Research Management Committee is a standing advisory committee to the Board of Directors responsible for providing oversight and direction on the execution and progress of Network research programs and projects.
Désirée Maltais, PhD PT, is an Associate Professor in the Department of Rehabilitation at Université Laval and a researcher at Centre for Interdisciplinary Research in Rehabilitation and Social Integration, in Québec City, Canada. Her research focuses on outcome measures related to mobility in children with CP and on the determinants and effects of physical activity in individuals with motor impairment. She is a licensed physical therapist with 20 years of clinical experience in pediatric rehabilitation. She is the past chair of the Adapted Sports and Recreation Committee of the American Academy of Cerebral Palsy and Developmental Medicine.
Dr. James Reynolds is a graduate of Queen’s University (B.Sc., 1982, Ph.D, 1987) and served as the interim chair of the Research Management Committee. His thesis research investigated the neurochemical mechanisms underlying heavy metal toxicity. Subsequently, he completed postdoctoral training at the Addiction Research Foundation and the University of Toronto. Dr. Reynolds’ first faculty position was at Memorial University in St. John’s, Newfoundland. He returned to Queen’s in 1995, where his research program has grown to encompass both basic and clinical investigations. Dr. Reynolds is a Full Professor in the Department of Biomedical and Molecular Sciences, and the Centre for Neuroscience Studies, at Queen’s University. His research interests over the past 20 years have centred around studies on the effects of alcohol on brain function. In particular, his current research program is focused on understanding the mechanisms of brain injury, and the resulting behavioural and cognitive deficits, that are induced by prenatal exposure to alcohol. The long term goal is to understand how prenatal exposure to alcohol alters brain neurochemistry and structure, and thus brain function, in offspring. Dr. Reynolds has been funded by CIHR for interdisciplinary basic and clinical investigations into the cellular mechanisms and neurobehavioural consequences of Fetal Alcohol Spectrum Disorder (FASD). He led a 7-member CIHR-funded New Emerging Team in FASD research, and is the Interim Chief Scientific Officer and Project Lead for the FASD Demonstration Project with Kids Brain Health Network. On March 8, 2019 Dr. Reynolds was appointed Chief Scientific Officer of Kids Brain Health Network.